Literature DB >> 9101559

Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk.

P J Goodwin1, N F Boyd, W Hanna, W Hartwick, D Murray, A Qizilbash, S Redwood, N Hood, M E DelGiudice, S Sidlofsky, D McCready, R Wilkinson, L Mahoney, P Connelly, D L Page.   

Abstract

Lipids and lipoproteins have been associated with breast cancer risk; however, published results have been inconsistent. To clarify these associations, we measured fasting lipids in women undergoing breast biopsies. A case-control study examined the association of fasting levels of lipids with histologically defined breast cancer risk. Four groups of premenopausal women were assembled on the basis of histological appearance of breast tissue: 1) no epithelial proliferation (n = 102), 2) proliferation without atypia (n = 53), 3) atypical hyperplasia or carcinoma in situ (n = 53), and 4) node-negative invasive cancer (n = 102). A postoperative fasting blood specimen was analyzed for cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides. Demographics, risk factors, diet, physical activity, fasting weight, and skin-fold thickness were measured. Triglyceride levels were significantly higher in women with node-negative invasive cancer (0.94 +/- 1.04 mg/ml) than in those with no epithelial proliferation (0.83 +/- 1.04 mg/ml, p = 0.03). This association persisted after adjustment for age, body size, lipids, reproductive and familial risk factors, and previous benign breast problems (p < 0.01), in keeping with an independent association of elevated triglycerides with breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101559     DOI: 10.1080/01635589709514539

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  12 in total

Review 1.  Lipid analogues as potential drugs for the regulation of mitochondrial cell death.

Authors:  Michael Murray; Herryawan Ryadi Eziwar Dyari; Sarah E Allison; Tristan Rawling
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2011-10-09       Impact factor: 3.201

3.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.

Authors:  Naima Badid; Fatima Zohra Baba Ahmed; Hafida Merzouk; Slimane Belbraouet; Nassima Mokhtari; Sid Ahmed Merzouk; Riad Benhabib; Djalloul Hamzaoui; Michel Narce
Journal:  Pathol Oncol Res       Date:  2010-06       Impact factor: 3.201

5.  Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins.

Authors:  D Jain; A Ray; A K Bahadur; K U Chaturvedi; R Sood; S Sharma; S L Naik; B K Sharma
Journal:  Indian J Clin Biochem       Date:  2001-01

6.  Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.

Authors:  Michael S Simon; Jennifer L Beebe-Dimmer; Theresa A Hastert; JoAnn E Manson; Elizabeth M Cespedes Feliciano; Marian L Neuhouser; Gloria Y F Ho; Jo L Freudenheim; Howard Strickler; Julie Ruterbusch; Ana Barac; Rowan Chlebowski; Bette Caan
Journal:  Cancer       Date:  2018-01-16       Impact factor: 6.860

7.  The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.

Authors:  Mei-Chi Hsu; Kuo-Ting Lee; Wei-Chiang Hsiao; Chih-Hsing Wu; Hung-Yu Sun; I-Ling Lin; Kung-Chia Young
Journal:  BMC Cancer       Date:  2013-07-05       Impact factor: 4.430

8.  Association between serum lipids and breast cancer risk in premenopausal women: systematic review and meta-analysis.

Authors:  Jing Wu; Xun Lei; Xianjun Pan; Xiaohua Zeng; Wei Li
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

9.  Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.

Authors:  Chi-Chen Hong; Bing-Kou Tang; Geoffrey L Hammond; David Tritchler; Martin Yaffe; Norman F Boyd
Journal:  Breast Cancer Res       Date:  2004-05-07       Impact factor: 6.466

10.  Association of Dyslipidemia, Increased Insulin Resistance, and Serum CA 15-3 with Increased Risk of Breast Cancer in Urban Areas of North and Central India.

Authors:  Poonam Kachhawa; Kamal Kachhawa; Divya Agrawal; Vivek Sinha; Purnima Dey Sarkar; Sanjay Kumar
Journal:  J Midlife Health       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.